Zhejiang Jingxin Pharmaceutical Co., Ltd. (SHE:002020)
China flag China · Delayed Price · Currency is CNY
12.41
+0.11 (0.89%)
Jun 12, 2026, 3:04 PM CST

SHE:002020 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
-530.71316.271,4611,5481,561
Trading Asset Securities
-318.96827.66150.96366.89422.4
Cash & Short-Term Investments
849.67849.671,1441,6121,9151,983
Cash Growth
21.65%-25.72%-29.03%-15.85%-3.41%-8.38%
Accounts Receivable
-881.12852.02612.58509.57510.67
Other Receivables
-49.2455.2651.4459.13103.81
Receivables
-930.36907.27664.02568.7614.47
Inventory
-766.15792.72652.69773.7677.69
Prepaid Expenses
-3.223.363.72.520.81
Other Current Assets
-751.4157.5421.5620.8817.82
Total Current Assets
-3,3012,9053,3543,2813,294
Property, Plant & Equipment
-2,2812,1882,3001,6321,297
Long-Term Investments
-1,4882,1611,1241,134882.21
Goodwill
-335.6348.48348.48348.48348.48
Other Intangible Assets
-431.89382.26401.26418.59157
Long-Term Deferred Tax Assets
-79.2383.5680.9875.1168.64
Long-Term Deferred Charges
-38.9358.7321.226.7155.95
Other Long-Term Assets
-167.59351.9356.72446.73443.95
Total Assets
-8,1248,4797,9877,3636,547
Accounts Payable
-666.34880.79941.16719.12449.79
Accrued Expenses
-225.72198.28206.39187.72189.47
Short-Term Debt
-284.39281.36279.09238.58148.33
Current Portion of Long-Term Debt
----0.050.27
Current Portion of Leases
-6.6313.311.8614.6914.66
Current Income Taxes Payable
-41.6589.1844.359.9950.25
Current Unearned Revenue
-56.4556.4853.3581.0147.61
Other Current Liabilities
-625.72615.12538.61514.23521.88
Total Current Liabilities
-1,9072,1352,0751,8151,422
Long-Term Debt
-----0.04
Long-Term Leases
-22.6323.1331.2342.9830.62
Long-Term Unearned Revenue
-263.91264.59268.81270.6128.73
Long-Term Deferred Tax Liabilities
-58.9654.3368.459.6865.44
Other Long-Term Liabilities
-0.861.193.21.940.74
Total Liabilities
-2,2532,4782,4462,1911,648
Common Stock
-861.03861.03861.03861.03905.32
Additional Paid-In Capital
-1,7231,7231,7231,7202,236
Retained Earnings
-3,8413,3682,9142,5542,150
Treasury Stock
--608.78----437.62
Comprehensive Income & Other
-16.6517.1713.8611.318.05
Total Common Equity
5,8335,8335,9705,5125,1464,862
Minority Interest
-37.2332.0427.7825.8537.72
Shareholders' Equity
5,8705,8706,0025,5405,1724,899
Total Liabilities & Equity
-8,1248,4797,9877,3636,547
Total Debt
313.65313.65317.79322.18296.3193.92
Net Cash (Debt)
536.02536.02826.131,2901,6191,789
Net Cash Growth
13.29%-35.12%-35.94%-20.35%-9.51%-4.00%
Net Cash Per Share
0.650.650.961.501.882.19
Filing Date Shares Outstanding
826.02813.76861.03861.03861.03861.03
Total Common Shares Outstanding
826.02813.76861.03861.03861.03861.03
Working Capital
-1,394770.261,2791,4661,872
Book Value Per Share
7.177.176.936.405.985.65
Tangible Book Value
5,0665,0665,2394,7634,3794,356
Tangible Book Value Per Share
6.226.226.085.535.095.06
Land
----0.21--
Buildings
-1,7971,6291,388934.82889.16
Machinery
-1,8401,7541,4121,219946.45
Construction In Progress
-52.7113.62482.06284.91161.34